Clinical Research Study
Trophy Skin Microdermabrasion Tools. A powerful revolution in home anti-aging skin care management targeting wrinkles, pore size and skin contour.
BACKGROUND/ OBJECTIVES
Premature aging has been a target for Dermatologists for decades, a specialized niche focusing on expensive treatments, multiple visits to the doctor’s office, and ultimately leading to high failure rates given the cost-benefit analysis. Premature aging continues to be a socioeconomic battle for most individuals.
MicrodermMD offers an at home solution to premature aging. MicrodermMD’s diamond-tip technology with vacuum suction device exfoliates and simultaneously removes debris from the skin to allow for effective rejuvenation.
This progressive clinical study highlights the effectiveness of MicrodermMD, not only in its capacity to reduce harsh effects of premature aging on the face, but extends its technology to the neck and chest regions. Furthermore, we showcase patient satisfaction, subjective improvements over a six-week period, and overall usability of the product.
STUDY DESIGN/MATERIALS & METHODS
PATIENTS:
Twenty two (22) female patients were randomly selected. Ages ranged from 35-55 (average 40 years old).
DEVICE:
MicrodermMD is an FDA registered dual action device that uses a diamond tip and vacuum technology.
TREATMENT PROTOCOL:
A six-week study analyzed patients in three time points including baseline (T1), three weeks (T2) and six weeks (T3). The patients were instructed to use the device 2-3 times per week. High-definition photographs were taken at T1 and T3. Each time point included questionnaires to track subjective progress of the patients.
An independent, blinded surgeon analyzed the data using Oral Commissure Severity Scale, Modified Glogau Scale (MGS), and a 6-Point Erythema Scale. Significant change was considered if here was a 1-point increase from T1 to T3.
RESULTS
Blinded Surgeon Evaluation shows a significant 75% reduction in fine lines, wrinkle depth and tone (spacing/ breadth) in all subjects using the oral commissure severity scale. Patients with moderate skin wrinkles at baseline in all facial regions (forehead, nasolabial, neck, chest) had the greatest decrease in wrinkle depth (p<0.05).
High definition pictures were analyzed as seen in Figures 1-4. 100% of the patients improved by at least 1-point on the Modified Glogau Scale (p<0.05) with a mean improvement of 1.5 +/- 0.4.
Further analysis revealed all anti-aging parameters significantly improved including solar lentigines, hyperpigmentation, forehead/peri-oral/nasolabial wrinkles, neck/chest/facial erythema, and diffuse telangiectasia from T1 to T3 (Table 1).
TABLE 1. Physician graded percent of patients with at least 2-point improvement
SUBJECTIVE QUESTIONNAIRE
Patients were required to analyze their own progress through T1, T2, T3 questionnaires. 29% at T1 believed their skin was pre-maturely aged and 29% categorized their skin as unhealthy.
At T3 100% of the patients reported their skin as hydrated and more youthful than ever before. Our patients reported solar lentigines, leathery skin, and sun damage to their neck/chest regions. Uniquely, MicrodermMD shows an 80% noticeable increase in improvement in patient’s premature neck/chest skin aging from baseline patient responses at 6 weeks based on a 10pt Improvement Scale revealed:
CONCLUSIONS
Premature aging has a socio-economic and psychological effects on individuals. In this study we showcased that individuals can take their skin health into their own hands and have significant results in anti-aging, not only on their face, but their neck/chest regions, an area difficult to treat. We show significant decrease in solar lentigines, wrinkles, and erythema safely without visiting a doctor’s office.
FIGURE 1. Before (Left) and 6 weeks after (Right) highlights decrease in wrinkle depth, tone, texture, with significant decrease in hyperpigmentation
FIGURE 2. Before (Left) and 6 weeks after (Right) shows makes reduction in solar lentigines, decrease depth of personal and nasolabial fine lines.
FIGURE 3. Baseline (Left) and 6 weeks after treatment (Right) shows a significant reduction in erythema from grade 5.0 to 2.0.
FIGURE 4. Baseline (Left) and 6 weeks after treatment (Right) shows makes decrease in deep neck fold wrinkles, chest erythema and solar lentigines.